Wells Fargo & Company »

Neurocrine Biosciences shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2012-06-30 $181k 22k 8.17
2011-09-30 $87k 14k 6.36
2010-12-31 $85k 11k 7.64

More positions owned by Wells Fargo & Company

Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Amazon Put Option (AMZN)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
UnitedHealth Call Option (UNH)
JPMorgan Chase & Co. Put Option (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Johnson & Johnson (JNJ)

View all positions for Wells Fargo & Company

Top funds holding Neurocrine Biosciences

Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Henderson Group
T. Rowe Price Associates
Point72 Asset Management
Dodge & Cox
DSM Capital Partners
Wellington Management Company
Brown Advisory Holdings Incorporated
Bank of New York Mellon
Deerfield Management Company
Franklin Resources
Jacobs Levy Equity Management
AQR Capital Management

View all funds holding Neurocrine Biosciences